PHARMA NEWS

Get the latest NEWS of Pharma World

Clinical trial testing topical cream plus influenza vaccine in progress
Pharma News
By admin / September 10, 2018

Clinical trial testing topical cream plus influenza vaccine in progress

A Phase 1 clinical trial...

Read More
Thermo Fisher To Acquire BD’s Advanced Bioprocessing Business
Pharma News
By admin / September 8, 2018

Thermo Fisher To Acquire BD’s Advanced Bioprocessing Business

Thermo Fisher Scientific Inc. (TMO)...

Read More
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Pharma News
By admin / September 8, 2018

Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow

Baxter International, Inc. (NYSE:BAX), a...

Read More
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
Pharma News
By admin / September 8, 2018

Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)...

Read More
Croma-Pharma GmbH Sets the Course for Entering the US Market
Pharma News
By admin / September 8, 2018

Croma-Pharma GmbH Sets the Course for Entering the US Market

On Sept 5th, Croma has...

Read More
Teewinot Life Sciences Corporation Announced Today Grant Of A Canadian Patent With Broad Claims To Biosynthetic Production Of Cannabinoids
Pharma News
By admin / September 7, 2018

Teewinot Life Sciences Corporation Announced Today Grant Of A Canadian Patent With Broad Claims To Biosynthetic Production Of Cannabinoids

Teewinot Life Sciences Corporation, a...

Read More
Janssen seeks FDA approval for esketamine nasal spray
Pharma News
By admin / September 7, 2018

Janssen seeks FDA approval for esketamine nasal spray

Janssen has submitted a New...

Read More
Gilead : Phase 2 TORTUGA Study Of Filgotinib Achieves Primary Efficacy Endpoint
Pharma News
By admin / September 7, 2018

Gilead : Phase 2 TORTUGA Study Of Filgotinib Achieves Primary Efficacy Endpoint

Gilead Sciences Inc. (GILD) and...

Read More
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata
Pharma News
By admin / September 7, 2018

Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata

Pfizer Inc. (NYSE:PFE) today announced...

Read More
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
Pharma News
By admin / September 6, 2018

Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases

Boehringer Ingelheim and Tsinghua University...

Read More
1 … 104 105 106 107 108 … 154
Offers